By Siddhi Mahatole March 30 (Reuters) - Viridian Therapeutics said on Monday its experimental drug met the main goal in a late-stage study, when tested in patients with active thyroid eye disease.

March 30 (Reuters) - Viridian Therapeutics said on Monday its experimental drug met the main goal in late-stage study, when tested in patients with active thyroid eye disease. The injectable drug, ...

The thyroid is a small gland present in the neck that produces hormones which are essential for growth, brain development, ...

Peer-reviewed research from the Clayman Thyroid Center at the Hospital for Endocrine Surgery highlights a major gap in ...

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today ...

Dark circles are popularly blamed only on fatigue and lack of sleep. However, some causes may be much deeper, shares Dr Jain.

MERCK, a leading science and technology company, hosted its second “She Matters: Women’s Health Summit” at Conrad Manila, ...

Viridian Therapeutics (NASDAQ:VRDN) shares fell 40% Monday following topline results from its elegrobart Phase 3 REVEAL-1 ...

Understand the signs of premature ovarian failure and POI. Learn how to manage symptoms and protect your long-term health.